RECENT NEWS

AI-powered pathology solutions provider Mindpeak has announced it has raised $15.3 million in a Series A funding round. This new investment will enable the company to further expand the commercialisation of its recently expanded suite of technologies across several new territories.

‘Breath biopsy’ firm Owlstone Medical has announced it has entered into a Research Collaboration Agreement with the US FDA’s Center for Devices and Radiological Health (CDRH) - Office of Science and Engineering Laboratories (OSEL). The goal of the collaboration is to develop methods for the confident identification of individual chemicals in the complex mixture of breath.

The Royal College of Pathologists (RCPath) has published a new Patient Safety and Quality Strategy as part of its ongoing aim to improve patient safety.

Global leaders have approved a political declaration at the 79th United Nations General Assembly (UNGA) High-Level Meeting on Antimicrobial Resistance (AMR), committing to a clear set of targets and actions, including reducing the estimated 4.95 million human deaths associated with bacterial antimicrobial resistance (AMR) annually by 10% by 2030.

Government-led negotiations on the world’s first agreement to protect people from future pandemics made significant progress during the latest round of discussions that ended recently at the World Health Organization (WHO).

Diagnostic firm Cepheid has announced a new partnership with the Fleming Initiative, a global collaboration established by Imperial College Healthcare NHS Trust and Imperial College London to combat antimicrobial resistance (AMR).

Two newly published Alzheimer’s studies reveal details of the disease’s biology, risk for progression, and the potential for a novel blood test.

StatLab Medical Products has launched a new self-manufactured premium slide and coverglass brand. The KT premium slides are designed for high-performance in busy pathology laboratories.

Roche has launched the cobas Respiratory flex test, the first to use Roche’s novel and proprietary TAGS (Temperature-Activated Generation of Signal) technology. It is able to detect up to 12 of the most common respiratory viruses with the flexibility for targeted testing.

The Medicines and Healthcare products Regulatory Agency (MHRA), is calling for applications for manufacturers and developers of Artificial Intelligence (AI) medical devices, to join the AI Airlock regulatory sandbox.

A research team led by NHS Blood and Transplant scientists based in Bristol, at NHSBT’s International Blood Group Reference Laboratory (IBGRL), and supported by colleagues at the University of Bristol, has discovered a new blood group, MAL, solving a 50-year-old mystery.

Beckman Coulter and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, have announced expansion of their long-term partnership to include a global distribution agreement forScopio’s Full-Field Bone Marrow Aspirate (FF-BMA) application.

A new survey from Abbott shows that leading infectious disease experts around the world believe significant gaps remain in building surveillance programmes to identify emerging pathogens, public health funding and having adequate testing infrastructure capabilities.

A Company Chemists’ Association (CCA) report urges the NHS to commission a community pharmacy diabetes screening service which would save the NHS £50m in recurring costs each year.

The Institute of Biomedical Science (IBMS) has collaborated with Hologic to produce a new report on digital cytology which it says promises enhanced efficiency, improved patient care, and solutions to workforce shortages, amid critical challenges in the UK's cervical screening programme.

Researchers from the Quadram Institute working together with the UK Health Security Agency (UKHSA) have established a human ‘lung-on-chip’ model that recreates how SARS-CoV-2 infects lung cells, in a contained laboratory environment.

Diagnostic firm MicrosensDx is working with The Mayr Group at Imperial College London to develop a novel biomarker test for the early recognition of sepsis. Based on MicrosensDx’s IP and technology, and designed to fit with existing diagnostic processes, this test could potentially fill a critical gap in patient management, offering clinicians a specific, quantitative diagnostic and prognostic solution to help prioritise appropriate treatment of sepsis.

A recent study published in Nature Machine Intelligence introduces an advanced artificial intelligence (AI) model capable of creating virtual colorations of cancer tissue. The study, co-led by scientists at the Universities of Lausanne and Bern, is a major step forward enhancing pathology analysis and diagnostics of cancer.

Roche has opened its new Pharma Research and Early Development (pRED) Center at its global headquarters in Basel, Switzerland. Equipped with cutting-edge technologies and housing around 1,000 state-of-the-art laboratory and office workplaces, the new centre brings together teams of scientists and researchers to accelerate scientific discoveries for patients.

Following the publication of Lord Darzi’s report into the NHS, the Institute of Biomedical Science (IBMS) and British In Vitro Diagnostics Association (BIVDA) have issued responses.